This story was updated with a statement from Abbott. A New Jersey federal judge has ruled that an age bias lawsuit from a former sales director at Abbott (NYSE:ABT) can move forward. Richard Rudolph alleged that, after 15 years as a sales director at the Abbott Park, Ill.-based medtech company, he was let go because […]
Abbott
Abbott wins EUA for COVID-19, flu, RSV combo assay
Abbott (NYSE:ABT) announced today that it received FDA emergency use authorization (EUA) for its Alinity m Resp-4-Plex molecular assay. The laboratory PCR diagnostic is designed to detect and differentiate between SARS-CoV-2 (the virus causing COVID-19), influenza A, influenza B and respiratory syncytial virus (RSV) in one test. It already has CE Mark approval and is […]
Abbott COVID-19 serology test gains EUA
Abbott (NYSE:ABT) this week received FDA emergency use authorization (EUA) for its AdviseDx SARS-CoV-2 IgG II diagnostic — providing another tool to detect people’s adaptive immune response to COVID-19. The serology test from Abbott Park, Ill.-based Abbott is indicated for the qualitative and semi-quantitative detection of IgG antibodies to SARS-CoV-2 — the virus causing COVID-19 […]
Abbott researchers help discover a clue to an HIV cure
Abbott announced today that a team including its scientists has uncovered a rare group of Democratic Republic of Congo residents who are HIV positive but have almost nonexistent viral loads without using antiretroviral treatments. This group of “HIV elite controllers” opens up a new area for researchers to discover biological trends that could inform the […]
Quidel wins FDA nod for at-home antigen test
The FDA issued an emergency use authorization today for the Quidel Corp. (NSDW:QDEL) QuickVue At-Home COVID-19 test, another antigen test to rapidly collect and test samples at home, without the need to send a sample to a laboratory for analysis. The QuickVue At-Home COVID-19 test is authorized for prescription home use with self-collected nasal swab […]
DTW Podcast: Zimmer Biomet slims, Corza Medical grows in pursuit of grabbing market share
In this week’s DeviceTalks Weekly Podcast, Rich Newitter, managing director at SVB Leerink, says Zimmer Biomet’s decision to spin out its spinal and dental business will accelerate its already impressive market share grab in its core orthopedics industry. Newitter says CEO Bryan Hanson brings a tried-and-true diversification model used by companies like his former employer, […]
MedTech 100 roundup: Index hits another all-time high
The beginning of February brought yet another peak for medtech stocks. MassDevice‘s MedTech 100 index ended the week (Feb. 5) at 108.23 points, marking a 4% rise from the 104.05-point mark set at the end of the previous week (Jan. 29). The final mark for the week sets an all-time best for the index, which had […]
3M, Abbott in top 50 of Fortune’s most admired companies list
Medtech giants 3M (NYSE:MMM) and Abbott (NYSE:ABT) made it into the top 50 of Fortune‘s 2021 World’s Most Admired Companies list. 3M — a manufacturing conglomerate that also has one of the largest medical device businesses in the world — came in at No. 24, up from No. 29 in the 2020 list. Abbott meanwhile was No. […]
MedTech 100 roundup: January ends with a dip
After spending several weeks on the ascent, medtech stocks leveled out a bit to end January, ending a run of several new highs in 2021. MassDevice‘s MedTech 100 index ended the week (Jan. 29) at 104.05 points, marking a -2.2% drop from the 106.4-point mark set at the end of the previous week (Jan. 22). The […]
COVID-19 test sales boost Abbott in Street-beating Q4
Abbott (NYSE:ABT) shares ticked up this morning on fourth-quarter results that bested the consensus forecast. The Abbott Park, Ill.-based company posted profits of $2.2 billion, or $1.20 per share, on sales of $10.7 billion for the three months ended Dec. 31, 2020, for a more than doubled bottom line on sales growth of 28.7%. Adjusted to […]
Abbott Panbio rapid antigen test wins CE mark for asymptomatic COVID-19 screening
Abbott (NYSE:ABT) announced today that it received CE Mark for two new uses of its Panbio COVID-19 Ag rapid diagnostic. Panbio COVID-19 Ag has received an updated label with clinical data on asymptomatic individuals to enable mass testing of people who do not currently present symptoms of the disease, according to a news release. The other […]